Gemcitabine in the Second-Line Therapy of Patients with Carcinoma of Unknown Primary Site: A Phase II Trial of the Minnie Pearl Cancer Research Network

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

1997 • 5,683 citations

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.

1994 • 364 citations

Advanced breast cancer: a phase II trial with gemcitabine.

1995 • 340 citations

Phase II Study of Gemcitabine (2',2'-Difluorodeoxycytidine) in Previously Treated Ovarian Cancer Patients

1994 • 332 citations

Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer.

1997 • 274 citations

Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma.

1999 • 235 citations

Treatment of the patient with adenocarcinoma of unknown origin

1972 • 164 citations

Metastatic Adenocarcinomas of Unknown Primary Site

1980 • 145 citations

Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.

1997 • 138 citations

5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary.

1986 • 71 citations

Management of patients with metastatic adenocarcinoma of unknown origin: a Southwest Oncology Group study.

1983 • 67 citations

Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloro platinum in patients with metastatic carcinoma of unknown primary origin

1991 • 63 citations

Lack of Value for Cisplatin Added to Mitomycin-Doxorubicin Combination Chemotherapy for Carcinoma of Unknown Primary Site A Randomized Trial

1987 • 55 citations

Fluorouracil, doxorubicin, cisplatin and altretamine in the treatment of metastatic carcinoma of unknown primary

1989 • 33 citations

RESPONSE OF PRIMARY UNKNOWN CANCERS TO TREATMENT WITH 5-FLUOROURACIL (NSC-19893).

1964 • 21 citations